艾瑞製藥 ARRY
-
-
-
已收盤：-
淨值比明細
年季 | 收盤價 | 權益總計(百萬) | 稅後權益報酬率(%) | 稅後純益(百萬) | 稅後資產報酬率(%) | 資產總計(百萬) |
|---|---|---|---|---|---|---|
| 2025Q1 | 4.87 | -98 | 17 | 1.17 | 1,426 | |
| 2024Q4 | 6.04 | -118 | -127 | -8.49 | 1,426 | |
| 2024Q3 | 6.60 | 64 | -106.90 | -141 | -8.79 | 1,563 |
| 2024Q2 | 10.26 | 200 | 11.92 | 26 | 1.57 | 1,652 |
| 2024Q1 | 14.91 | 231 | 0.88 | 2 | 0.13 | 1,629 |
| 2023Q4 | 16.80 | 259 | 7.19 | 19 | 1.11 | 1,707 |
| 2023Q3 | 22.19 | 278 | 6.84 | 19 | 1.07 | 1,779 |
| 2023Q2 | 22.60 | 287 | 24.78 | 61 | 3.36 | 1,853 |
| 2023Q1 | 21.88 | 207 | 15.76 | 26 | 1.49 | 1,794 |
| 2022Q4 | 19.33 | 124 | -5.64 | -5 | -0.31 | 1,706 |
| 2022Q3 | 16.58 | 62 | 70.83 | 45 | 2.58 | 1,682 |
| 2022Q2 | 11.01 | 64 | -1.56 | -1 | -0.08 | 1,770 |
| 2022Q1 | 11.27 | 108 | -22 | -1.54 | 1,716 | |
| 2021Q4 | 15.69 | -69 | -22 | -2.28 | 1,143 | |
| 2021Q3 | 18.52 | 7 | -22 | -3.11 | 777 | |
| 2021Q2 | 15.60 | -69 | -2 | -0.28 | 622 | |
| 2021Q1 | 29.82 | -70 | 3 | 0.47 | 583 | |
| 2020Q4 | 43.14 | -81 | -10 | -1.62 | 656 | |
| 2020Q3 | 377 | -7 | -1.34 | 552 | ||
| 2020Q2 | -205 | 2 | 531 |